We are live on ! Find out more
NIP

Nicholas Investment Partners Portfolio holdings

AUM $1.39B
1-Year Est. Return 97.11%
This Fund
S&P 500
This Quarter Est. Return
+10.75%
1 Year Est. Return
+97.11%
3 Year Est. Return
+361.61%
5 Year Est. Return
+496.81%
10 Year Est. Return
+3,647.83%
AUM
$1.14B
AUM Growth
+$47.3M
Cap. Flow
-$93.6M
Cap. Flow %
-8.23%
Top 10 Hldgs %
18.14%
Holding
253
New
32
Increased
64
Reduced
41
Closed
33

Top Sells

Rank Stock Value
1
TMDX icon
Transmedics
TMDX
+$13.7M
2
HALO icon
Halozyme
HALO
+$10.2M
3
CVCO icon
Cavco Industries
CVCO
+$9.29M
4
MTG icon
MGIC Investment
MTG
+$8.12M
5
RRR icon
Red Rock Resorts
RRR
+$6.73M

Sector Composition

Rank Sector Weight
1 Technology 23.1%
2 Industrials 21.35%
3 Healthcare 13.07%
4 Financials 11.12%
5 Consumer Discretionary 9.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPSC icon
51
SPS Commerce
SPSC
$2.64B
$7.22M 0.64%
39,239
+2,500
+7% +$469K
VRNA
52
DELISTED
Verona Pharma
VRNA
$7.19M 0.63%
+154,814
New +$5.81M
SNPS icon
53
Synopsys
SNPS
$79.7B
$7.06M 0.62%
14,549
-700
-5% -$366K
ARIS
54
DELISTED
Aris Water Solutions
ARIS
$6.96M 0.61%
290,758
+16,855
+6% +$366K
CCJ icon
55
Cameco
CCJ
$42.4B
$6.91M 0.61%
134,545
+201
+0.1% +$10.9K
FRPT icon
56
Freshpet
FRPT
$3.22B
$6.87M 0.6%
46,361
+1,892
+4% +$276K
ONTO icon
57
Onto Innovation
ONTO
$15.3B
$6.83M 0.6%
40,966
-15,114
-27% -$2.76M
ISRG icon
58
Intuitive Surgical
ISRG
$134B
$6.75M 0.59%
12,932
CRNX icon
59
Crinetics Pharmaceuticals
CRNX
$8.92B
$6.51M 0.57%
127,283
+33,423
+36% +$1.87M
SFM icon
60
Sprouts Farmers Market
SFM
$8.01B
$6.44M 0.57%
+50,660
New +$6.73M
IWO icon
61
iShares Russell 2000 Growth ETF
IWO
$15.1B
$6.42M 0.56%
22,291
+1,517
+7% +$449K
XPO icon
62
XPO
XPO
$23.7B
$6.28M 0.55%
47,861
HQY icon
63
HealthEquity
HQY
$8.75B
$6.21M 0.55%
+64,747
New +$6.03M
MIRM icon
64
Mirum Pharmaceuticals
MIRM
$6.14B
$6.15M 0.54%
148,843
+4,364
+3% +$182K
EXE
65
Expand Energy Corp
EXE
$21.5B
$6.12M 0.54%
61,500
BA.PRA
66
Boeing Co 6.00% Series A Preferred Stock
BA.PRA
$8.27B
0
CR icon
67
Crane Co
CR
$12.7B
$6M 0.53%
39,541
-10,977
-22% -$1.81M
NUVL
68
DELISTED
Nuvalent
NUVL
$5.98M 0.53%
76,427
-23,644
-24% -$2.21M
MWA icon
69
Mueller Water Products
MWA
$4.16B
$5.95M 0.52%
264,267
+10,662
+4% +$250K
KVYO icon
70
Klaviyo
KVYO
$4.73B
$5.8M 0.51%
140,555
+54,509
+63% +$2.08M
FN icon
71
Fabrinet
FN
$20.1B
$5.74M 0.51%
26,120
+5,698
+28% +$1.37M
WFRD icon
72
Weatherford International
WFRD
$6.22B
$5.49M 0.48%
76,653
-26,605
-26% -$2.18M
PRCT icon
73
Procept Biorobotics
PRCT
$1.17B
$5.49M 0.48%
68,137
+2,777
+4% +$237K
AAPL icon
74
Apple
AAPL
$4.57T
$5.22M 0.46%
20,843
+1,336
+7% +$315K
SG icon
75
Sweetgreen
SG
$642M
$5.19M 0.46%
162,019
+33,506
+26% +$1.25M

Similar funds

Nicholas Investment Partners's Q4 2024 Portfolio in Review

As of Q4 2024, Nicholas Investment Partners held 253 positions worth $1.14B, up 4.3% from $1.09B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Nicholas Investment Partners withdrew a net $93.6M in Q4 2024, closing 33 positions and reducing 41 holdings. Its most notable exit was Transmedics, an estimated $13.7M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Industrials and Healthcare.

Against the trend, Nicholas Investment Partners opened a new position in Rush Street Interactive worth $15M.

  • Nicholas Investment Partners's largest Q4 2024 buy was Rush Street Interactive: 1,091,091 shares worth $15M.
  • Nicholas Investment Partners added most to iShares Russell 2000 ETF in Q4 2024, an estimated $6.59M increase.
  • Nicholas Investment Partners's biggest Q4 2024 reduction was Halozyme, cutting an estimated $10.2M.
  • Nicholas Investment Partners fully exited Transmedics in Q4 2024, selling an estimated $13.7M.
  • Nicholas Investment Partners's ten largest holdings make up 18% of its $1.14B portfolio in Q4 2024.
  • Nicholas Investment Partners opened 32 new positions and closed 33 in Q4 2024.
  • Nicholas Investment Partners's portfolio value rose 4.3% quarter-over-quarter to $1.14B.

Based on Nicholas Investment Partners's 13F filing for Q4 2024, filed 14 Feb 2025.